U.S. Oil and Gas Stock News

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

In the past week, Best Buy reported quarterly results showing adjusted EPS of US$2.61, up 1.2% year over year, alongside a 0.8% decline in comparable sales and slightly softer-than-expected revenue, while also announcing a 1% increase in its quarterly dividend to US$0.96 per share. Management’s decision to raise the dividend and emphasize scalable profit drivers such as its digital Marketplace and Best Buy Ads highlights a focus on recurring, higher-margin revenue streams even as top-line...

If you are wondering whether Cal-Maine Foods at around US$77.12 is pricing in too much optimism or leaving some value on the table, a closer look at its valuation can help frame that question. The share price is near US$77.12 after a 0.1% move over the last 7 days, with an 11.5% decline over 30 days, a 1.7% decline year to date, a 7.8% decline over 1 year, but a 53.8% gain over 3 years and a 159.0% gain over 5 years. Recent coverage has focused on Cal-Maine Foods as a key player in the US...

CDW stock performance context CDW (CDW) has drawn attention after a period where the share price shows a 2.5% decline over the past day and negative returns over the week, month, past 3 months, year to date, and past year. See our latest analysis for CDW. At a share price of $118.17, CDW’s recent 1 day share price decline of 2.5% sits within a broader period of weaker momentum, with a 1 year total shareholder return of 25.0% in the red. This may reflect cooler sentiment around its risk and...

If you are wondering whether lululemon athletica's current share price really reflects what the business is worth, starting with a clear look at valuation can help you frame that question properly. The stock last closed at US$145.85, with returns of an 11.3% decline over 7 days, a 21.2% decline over 30 days, a 30.8% decline year to date, and a 48.5% decline over the past year, which has likely shifted how many investors think about its potential and risk. Recent headlines around lululemon...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Morningstar...

Electronic Arts (NasdaqGS:EA) has completed a multi billion dollar private equity takeover, reshaping its ownership structure. JPMorgan Chase & Co. arranged complex financing to close the leveraged buyout in challenging market conditions. Management is highlighting plans to use artificial intelligence to drive the next phase of the company’s growth focus. For investors watching NasdaqGS:EA, the completed deal comes with the stock at $202.01 and a 1 year return of 40.4%. Over 3 years, the...

What stands out about Stock Yards Bancorp right now Stock Yards Bancorp (SYBT) has drawn attention after recent trading left the shares around $63.91, with returns showing small single digit moves over the past week, month, and past 3 months. See our latest analysis for Stock Yards Bancorp. While the 1 day share price return of 2.31% and year to date share price return of 1.98% are both negative, the 3 year total shareholder return of 24.86% and 5 year total shareholder return of 37.15%...

Why American Public Education is on investors’ radar today American Public Education (APEI) is drawing attention after recent trading data highlighted strong momentum in its share price over the past month and past 3 months, prompting fresh interest in its fundamentals. See our latest analysis for American Public Education. At a share price of $57.24, American Public Education has seen strong recent momentum, with a 30 day share price return of 24.92% and a 1 year total shareholder return of...

Wondering whether CVS Health at around US$70 still offers value, or if the easy money has already been made? This article walks through the key numbers so you can judge for yourself. The stock is around US$70.08 after a 1.7% decline over the past week and double digit declines of 12.3% for the past month and 12.5% year to date, even though the 1 year return sits at 7.4% and the 3 and 5 year returns are 3.4% and 10.0% respectively. Recent headlines around CVS Health have focused on its role...

Western Digital joined an open source quantum error correction initiative with Open Quantum Design and QuScript, targeting more reliable quantum computing. The collaboration focuses on setting shared standards and protocols for fault tolerant quantum systems. The move expands Western Digital's role beyond storage into quantum computing reliability and system level error correction. Western Digital (NasdaqGS:WDC) enters this partnership with a share price of $275.34 and very large 1 year and...

Burford Capital recently reported that the US Court of Appeals for the Second Circuit reversed the prior District Court judgment in favor of Petersen and Eton Park in the long-running YPF litigation, prompting the company to review the case’s carrying value and consider a potentially material asset write-down in its upcoming first-quarter results. This reversal directly affects a case that represents a large share of Burford’s fair value assets, underscoring how concentrated legal exposures...

In March 2026, VNET Group, Inc. reported that fourth-quarter 2025 sales rose to CNY 2,687.09 million and net income reached CNY 304.67 million, reversing a net loss a year earlier, while full-year 2025 sales increased to CNY 9,949.26 million despite a net loss of CNY 251.84 million. The company also issued full-year 2026 guidance calling for total net revenues of RMB 11.5–11.8 billion, highlighting management’s confidence in sustaining double-digit growth in its data center business despite...

Alibaba Group Holding Limited has already reported its third-quarter and nine-month results to December 31, 2025, showing modest sales growth but a sharp drop in net income and earnings per share versus the prior year. At the same time, Alibaba is preparing to adopt Huawei's new 950PR AI processor as US restrictions on Nvidia hardware push it toward domestically produced chips for its cloud and data center infrastructure. We’ll now examine how Alibaba’s shift toward Huawei’s 950PR AI chips...

Why ACI Worldwide (ACIW) Is On Investors’ Radar Today ACI Worldwide (ACIW) is drawing attention after recent share price pressure, with the stock showing negative returns over the past week, past 3 months and year, even as revenue and net income figures remain positive. See our latest analysis for ACI Worldwide. At a share price of $39.88, ACI Worldwide has experienced short-term pressure, with recent share price returns weaker over the past quarter and year. However, the 3-year total...

AnaptysBio has approved the spin off of First Tracks Biotherapeutics, with shareholders set to receive one First Tracks share for each AnaptysBio share held. First Tracks Biotherapeutics is expected to list on Nasdaq and will be funded through capital from AnaptysBio and a private placement. The company has added experienced industry executive Susannah Gray to its board as part of the transition. The spin off comes as AnaptysBio, listed as NasdaqGS:ANAB, is in focus with a current share...

Wondering if DocuSign at around US$45.71 is a bargain or still pricing in big expectations? This article walks through what the current share price might be implying about value. The stock has had a mixed run, with a 1.4% return over 30 days, a 29.5% decline year to date, and a 43.8% decline over the last year. These moves can change how the market views both risk and potential reward. Recent coverage has focused on DocuSign's position in digital agreements and how investors are reassessing...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with anticipated earnings growth of 15% annually in the coming years. In this dynamic environment, identifying promising small-cap stocks with insider buying can offer unique opportunities for investors seeking potential value amidst fluctuating market conditions.

Over the last 7 days, the United States market has dropped 1.9%, yet it has risen by 15% over the past year, with earnings forecast to grow annually by the same percentage. In this context of fluctuating short-term performance and promising long-term growth prospects, identifying high-growth tech stocks can be a strategic approach for investors looking to capitalize on innovation-driven sectors.

Recent commentary on A. O. Smith highlights that the water heater and treatment manufacturer has faced end‑market headwinds, with sales broadly flat and earnings per share growing more slowly than peers over the past two years. Analysts also point to weakening returns on capital, suggesting that some of A. O. Smith’s historically profitable areas may now be delivering less incremental benefit. We’ll now examine how persistent end‑market challenges, particularly flat sales, may influence A...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In such conditions, identifying stocks that may be trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets in a growing market.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In this environment, identifying growth companies with high insider ownership can be advantageous as they often signal confidence in long-term prospects and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped 1.9%, while showing a notable 15% rise over the past year, with earnings expected to grow annually by the same percentage. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential becomes crucial for investors seeking stability and opportunity. Penny stocks, though an older term, still signify smaller or emerging companies that can offer significant value; when these companies have solid...

Icahn Enterprises (IEP) has drawn fresh attention after recent trading left the units at a last close of US$7.45, with returns mixed across recent periods and a value score of 4 catching investor interest. See our latest analysis for Icahn Enterprises. Recent trading has been soft, with a 1 day share price return of 2.74% and a 30 day share price return of 7.57%. The 1 year total shareholder return of 3.47% contrasts with a 3 year total shareholder return of 72.93% and a 5 year total...